StevenMFruchtmanMD

PubMed

• 22 citations
  Predictive value of left ventricular ejection fraction in stem cell transplantation.
  M. Zangari, Milena J. Henzlova, S Ahmad, Eileen Scigliano, Luis Isola
  Bone Marrow Transplantation. 1999-05-01
• 20 citations
  Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation
  Celia Grosskreutz, Virginia Ross, Eileen Scigliano, Steven M. Fruchtman, Luis Isola
  Biology of Blood and Marrow Transplantation. 2003-07-01
• 174 citations
  From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
  Steven M. Fruchtman, K Mack, M E Kaplan, P Peterson, Berk Pd
  Seminars in Hematology. 1997-01-01

Abstracts/Posters

• Genomic Profiling in Patients with Higher-Risk Myelodysplastic Syndrome (HR-MDS) Following HMA Failure: Baseline Results from the Inspire Study (04-30)
  Steven M. Fruchtman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase 3, Multi-Center, International, Randomized, Double-Blind, Placebo Controlled Study of Oral Rigosertib + Injectable Azacitidine (AZA) Versus Injectable Azacitidin...
  Steven M. Fruchtman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Truncation Products of Stromal Cell Derived Factor-1 (CXCL12) Quantified By Mass Spectrometry in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018